Ziad Issa, MD
Clinical Cardiac Electrophysiology · Springfield, ILNPI 1740362094
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (43.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 96.4% of it on its own, with 16 other manufacturers making up the rest. Among clinical cardiac electrophysiology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 255 payments — averaging $794.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$195K
- Abbott$4K
- Biosense Webster, Inc.$1K
- Medtronic$772
- Atricure, Inc.$398
- Cardiva Medical, Inc.$127
- plus $414 from 11 others
Across 325 payments — averaging $2983.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$727K
- Medtronic$194K
- Atricure, Inc.$26K
- Elutia, Inc.$23K
What the payments were for
- Consulting fees$87,70043%
- Speaking & faculty fees$83,23441%
- Travel & lodging$21,79711%
- Food & beverage$9,7205%
- Gifts$420%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 192 | $195,237 |
| Abbott | 25 | $4,471 |
| Biosense Webster, Inc. | 8 | $1,074 |
| Medtronic | 8 | $772 |
| Atricure, Inc. | 2 | $398 |
| Cardiva Medical, Inc. | 1 | $127 |
| Electromed, Inc. | 3 | $102 |
| Preventice Services, LLC | 2 | $62 |
| Pfizer | 4 | $58 |
| Welch Allyn | 1 | $42 |
| Johnson & Johnson | 2 | $40 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $36 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Novartis | 1 | $16 |
| Amgen | 1 | $16 |
| Actelion Pharmaceuticals US, Inc. | 1 | $13 |
| Acutus Medical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rhythmia Mapping System$52,061
- GENERAL - THERAPIES$39,454
- RHYTHMIA$20,866
- Farapulse$16,927
- GENERAL EP$11,484
- AVEIR$3,814
- SPECTRA WAVEWRITER$838
- Carto 3$750
- Micra$294
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$286
- PatientCare Link$212
- WATCHMAN Access System$184
- OMNIASECURE MRI SURESCAN$146
- Cardiva VASCADE MVP VVCS 6-12F$127
- DIAMONDTEMP BIDIRECTIONAL ABLATION CATHETER$123
- EPI-SENSE GUIDED COAGULATION SYS$112
How this compares
$202,494 in reported general payments places this provider in the 90th percentile of 158 clinical cardiac electrophysiology providers in Illinois.
See all clinical cardiac electrophysiology providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 701 | $719,171 |
| XareltoRivaroxaban | 148 | $141,858 |
| Dofetilide | 261 | $109,854 |
| Flecainide Acetate | 213 | $8,350 |
| Propafenone Hcl ErPropafenone Hcl | 22 | $4,466 |
| Metoprolol Succinate | 237 | $3,926 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 16 | $3,363 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 73 | $2,306 |
| Amiodarone Hcl | 216 | $1,735 |
| Propafenone Hcl | 23 | $724 |
| SotalolSotalol Hcl | 49 | $691 |
| Diltiazem 24hr ErDiltiazem Hcl | 14 | $604 |
| Metoprolol Tartrate | 18 | $270 |
| Carvedilol | 44 | $242 |
| Losartan Potassium | 27 | $237 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $58 | $719,171701 claims |
| Johnson & JohnsonXarelto | $40 | $141,858148 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 158 clinical cardiac electrophysiology providers in Illinois.
Other clinical cardiac electrophysiology in Springfield
- Abdur Rahman AhmadSpringfield$46K
- Cody WilliamsSpringfield$36K
- Mansour RazminiaPalos Heights$927K
- Mark MetzlEvanston$799K
- Roderick TungChicago$795K
- Bradley KnightChicago$661K
- Gaurav UpadhyayChicago$593K
- Henry HuangGeneva$501K
- Kousik KrishnanNaperville$311K
- Hany DemoChicago$297K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.